Targeting mutated plus germline epitopes confers pre-clinical efficacy of an instantly formulated cancer nano-vaccine by Mohsen, Mona O., Vogel, Monique, Riether, Carsten, Muller, Julius, Salatino, Silvia, Ternette, Nicola, Gomes, Ariane C., Cabral-Miranda, Gustavo, El-Turabi, Aadil, Ruedl, Christiane, Kundig, Thomas M., Dermime, Said, Knuth, Alexander, Speiser, Daniel E., Bachmann, Martin F.

Get full text
Get full text